
In June 2026, as hundreds of Midwesterners began showing up at emergency rooms with the explosive diarrhea, cramping, and fatigue that mark a Cyclospora infection, something unusual happened. State health departments caught the outbreak first. They always do in the early days. But this time, the gap between what states knew and what the CDC officially reported kept widening and never closed.
By mid-July, Michigan had documented more than 5,000 cases of cyclosporiasis linked to contaminated iceberg lettuce from a Mexican farm. The CDC’s official count, posted on its outbreak page days later, listed 1,645. That discrepancy, a gap of thousands of cases that persisted for weeks, is the kind of data failure that keeps public health veterans awake at night.
“This is not something we have seen in the last 15 years,” one official familiar with the investigation told CNN, speaking on condition of anonymity.
The lag is not a technical glitch or a seasonal anomaly. It is the downstream symptom of a deliberate, systematic dismantling of the machinery the United States depends on to detect infectious disease threats before they become crises.
The Erosion of the Lab
The CDC’s Division of Parasitic Diseases and Malaria was never a large operation. But it was a vital one. It housed the country’s only federal reference laboratory for parasites like Cyclospora, organisms that most American doctors never encounter in training but that sicken tens of thousands of people each year through contaminated produce.
Dr. Joel Barratt ran that lab. He was the head of the team that did the DNA sequencing work needed to match patient stool samples to a common source, the molecular forensics that lets investigators trace an outbreak from a sick person in Ohio back to a specific farm in central Mexico.
By the time Barratt resigned in September 2025, his team had shrunk from 11 people to three. Hiring freezes under the expiring Title 42 authority meant he could not renew contracts for the specialized molecular biologists and bioinformaticians he needed. The division lost roughly $30 million in funding after the Trump administration dismantled USAID, which had been the primary financial backer of the parasitic diseases program. The funding had supported shared laboratory equipment, sequencing reagents, and the deep bench of personnel who could be pulled into outbreak investigations at a moment’s notice.
Barratt sent emails to CDC leadership before he left, warning that the loss of staff and expertise would slow future outbreak responses. “The changes have affected our ability to respond to outbreaks overall,” he told CNN after his departure. “That was a lot even before the cuts.”
A Broken Chain
Disease surveillance is not one thing. It is a chain of connected operations: a clinician who recognizes an unusual illness and orders the right test. A state lab that runs the diagnostic panel and uploads the result. A federal database that ingests those reports. A team of epidemiologists who spot the clustering and dispatch a field investigation. A molecular lab that sequences the pathogen and matches it to a source. A public communication that alerts the rest of the country.
Every link has been weakened.
When the CDC lost roughly a quarter of its workforce in 2025 through reduction-in-force cuts, the losses were not evenly distributed. Senior leaders, field epidemiologists, and specialized lab scientists were among the first to go. The agency shed nearly 3,000 employees, many of them career professionals who knew how to mobilize a response in hours, not weeks.
Debra Houry, the CDC’s former chief medical officer, put it bluntly in a recent interview. “When you lose 25 to 30 percent of staff and 80 percent of senior leaders and have no careers in the office of the director, there is an impact.”
The impact is visible in the data. Slowed data entry at the federal level means case counts lag behind reality. Slower lab analysis means that by the time the CDC confirms a contamination source, the contaminated product may have moved through the supply chain to new states. In the case of the Cyclospora outbreak, Taylor Farms recalled all iceberg lettuce sourced from central Mexico on July 17, but the agency’s own investigation page noted that the true number of sick people was “likely higher than the number reported.”
Speed Is the Only Advantage
In infectious disease response, speed is everything. Every day of delay in identifying a contaminated food product means more people eating it. Every week of lag in sequencing a pathogen means more cases that cannot be linked. Every month of hiring freeze means expertise that walks out the door does not come back.
Dr. Dan Jernigan, former director of the CDC’s Emerging and Zoonotic Infectious Disease Division, stepped down in August 2025. Watching the Cyclospora response from outside, he noticed a shift he had never seen in his decades at the agency.
“I don’t see the same level of urgency,” Jernigan said. “I cannot say whether this is tied to organizational restructuring, resource reductions, other operational decisions, or simply a different approach to this outbreak. What I can say for sure is that the contrast with my experience at the CDC is noticeable.”
Dr. Michael Osterholm, director of the Center for Infectious Disease Research and Policy at the University of Minnesota, echoed the concern. He noted that the response lacked the rapid mobilization and coordination that characterized previous foodborne outbreak investigations.
Beyond Cyclospora
The cyclosporiasis outbreak is the most visible example of degraded surveillance capacity, but it is far from the only one. In early 2025, the largest measles outbreak in 33 years spread across Texas and into neighboring states, fueled by declining vaccination rates and a public health infrastructure that could no longer keep pace with contact tracing. Laboratory leaders who should have been on the front lines of the measles response were among those laid off in the first wave of cuts.
In May 2026, a hantavirus outbreak in the Southwest exposed similar vulnerabilities. The CDC was not running the usual playbook for outbreak response and communication. The pattern was the same: delayed data, slow lab confirmation, an agency operating on a skeleton crew.
These are not unrelated failures. They are the predictable consequence of an agency that has lost both its people and its institutional memory. When a division can no longer pull in specialists from malaria or chronic tropical disease units to help with a Cyclospora outbreak, when data entry training for a new disease has not been conducted because of administration restrictions, when the people who knew how to make the system work have resigned, the system stops working.
Rebuilding After the Fire
The Trump administration has acknowledged the problem, at least in part. The fiscal 2027 budget proposal includes an additional $33 million for food safety. But former officials and current staff say the damage is already done.
Rebuilding public health surveillance capacity is not a one-year project. The scientists who knew how to sequence the Cyclospora genome, who had spent a decade developing the laboratory techniques to extract DNA from a parasite with a hard, resilient exterior, cannot be replaced overnight. The molecular typing tools that turned a microscopic organism into a traceable data point were the product of years of dedicated research by a team that no longer exists.
“We used to be able to compare stool DNA from patients to identify a common source and quickly determine where the outbreak was coming from, from the farm to the distributor,” Barratt said. Now, with fewer hands, less shared equipment, and a severed funding pipeline, that work takes longer. In outbreak response, longer means wider.
The $33 million pledged for 2027, if it materializes, will help. But it will not bring back the 11-person team that knew how to find a parasite in a haystack. It will not restore the 3,000 employees who took their expertise with them when they left. And it will not rebuild, in a single budget cycle, the surveillance infrastructure that the United States spent decades constructing and roughly 18 months dismantling.
The Cyclospora outbreak of July 2026 will eventually be resolved. The contaminated lettuce has been recalled. The sick will recover. But the question this episode leaves hanging is not whether the CDC can handle this outbreak. It is whether it can handle the next one, and the one after that, with a surveillance system that has been hollowed out from the inside.

